U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

A new evidence review says that coffee and tea consumption are linked to a lower risk of cancers of the mouth, throat, and ...

McDaniel College begins a $3.6 million renovation to install a learning commons in the Hoover Library in Westminster ...

Eli Lilly and Company (NYSE: LLY) shares are trading higher Monday. The upward momentum in the stock comes after the FDA approved the company's Zepbound, a weight loss drug designed to treat ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...

Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of ...

The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, ...

Grants will support efforts nationwide to strengthen Christian congregations in small towns and rural areas ...